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Objectives: Notwithstanding preoperative staging, a number of procedures still end in an exploratory thoracot-
omy as a result of unexpected findings. The aim of this work is to evaluate the validity of routine videothoraco-
scopy, performed as the first step of every planned resection for non–small cell lung cancer, to assess tumor
resectability and feasibility of the resection through thoracoscopy.
Methods and Results: From November 1991 to December 2007, in our department, 1306 patients with non–
small cell lung cancer, judged operable at conventional staging, underwent videothoracoscopy before the oper-
ation. Thoracoscopy revealed inoperability in 58 (4.4%) patients, mostly owing to pleural dissemination (2.5%)
or mediastinal infiltration (1.7%). In the remaining 1248 (95.6%), thoracoscopy did not reveal inoperability. Of
these, 449 (34.4%) underwent thoracoscopic resection. The other 799 (61.2%) underwent thoracotomy: 767
underwent resection, but 32 (2.5%) had an exploratory thoracotomy. Thoracoscopy had suggested unresectability
in 7 (0.5%) patients, had been incompletely carried out in 4 (0.3%), and was unfeasible in 21 (1.6%) owing to
insurmountable technical reasons. In our previous series from 1980 to 1991 the exploratory thoracotomy rate had
been 11.6%. In the present series, after the introduction of routine thoracoscopy in the staging process, the
exploratory thoracotomy rate was 2.5%. Thoracoscopy was reliable in excluding unresectability (negative pre-
dictive value 0.97). The global percentage of correct staging was significantly better (P<.0001) by thoracoscopy
(73.3%) than by computed tomography (48.7%). Considering T descriptor, video-assisted thoracic surgery
correctly matched with final pathologic staging in 96.2% of patients.
Conclusions: Routine preliminary videothoracoscopy ensured assessment of tumor resectability and feasibility
of the resection through thoracoscopy and limited unnecessary thoracotomies.
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Notwithstanding recent improvement of conventional diag-
nostic tools and the introduction of new technologies of
metabolic imaging (fluorodeoxyglucose positron emission
tomography [FDG-PET] or positron emission tomogra-
phy–computed tomography [PET-CT]), clinical staging is
sometimes not confirmed by intraoperative findings. A con-
siderable number of procedures still end in a mere explor-
atory thoracotomy, or distant metastases are unveiled only
a few months after the operation.1-7 A minimally traumatic
method, such as thoracoscopy, could help in decreasing
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sures a direct view of the lesion and an adequate surgical
exploration. In the past, preoperative thoracoscopy for stag-
ing was used only in selected cases of pleural effusion with-
out malignant cells, to assess pleural involvement. After the
initial experviences in 1991, we8 decided to perform routine
thoracoscopic exploration in every patient with non–small
cell lung cancer (NSCLC) judged a candidate for pulmonary
resection after conventional clinical staging.
The aim of this work is to present our experience with vid-
eothoracoscopic surgical staging for lung cancer, systemat-
ically carried out as the first step of the planned surgical
procedure.
PATIENTS AND METHODS
From November 1991 to December 2007, 1761 patients were admitted
with a diagnosis of lung cancer. The clinical charts of the patients have
been retrospectively reviewed with particular attention to preoperative stag-
ing, surgical description, postoperative course, and histologic type. Data
have been entered in a dedicated database and analyzed by SPSS 16.0 soft-
ware (SPSS, Inc, Chicago, Ill). Fully informed consent to the planned sur-
gical strategy and procedure, as well as authorization to use personal data
for scientific purposes, had been obtained from each patient at hospital ad-
mission or immediately before the procedure.
Preoperative staging included chest radiographs, CT scan of the thorax,
upper abdomen, and brain, and bronchoscopy.Mediastinoscopy was carried
out in cases of suspected N3 disease or extracapsular N2 invasion. PET
scanning has been easily available to us only since 2005 and has beenrgery c November 2009
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CT ¼ computed tomography
FDG-PET ¼ fluorodeoxyglucose positron
emission tomography
NSCLC ¼ non–small cell lung cancer
PET ¼ positron emission tomography
VATS ¼ video-assisted thoracic surgery
performed only on selected patients with mediastinal lymph node enlarge-
ment or patients with doubtful pulmonary or distant lesions.
Clinical evaluation ruled out cancer or revealed a medical condition pre-
cluding surgery in 210 patients. In another 245 patients with confirmed lung
cancer, conventional staging found an unequivocal cause of inoperability.
The remaining 1306 consecutive patients with lung cancer, candidates for
curative surgery after conventional staging, were submitted to videothora-
coscopic exploration immediately before the planned operation (Figure 1).
Technique
We9 have already described the technical details of video-assisted thoracic
surgical (VATS) exploration elsewhere. The patient, in the lateral decubitus
position as for a conventional thoracotomy, is intubated with a double-lumen
tube for selective lung ventilation. Three ports are inserted in the seventh in-
tercostal space on the midaxillary line and in the fifth intercostal space, ante-
riorly and posteriorly, along the incision line of the possible thoracotomy.
Reusable instruments are employed. Systematic exploration from the apex
to the diaphragm requires the lysis of pleural adhesions and the complete mo-
bilization of the lungbydividing the pulmonary ligament.Videothoracoscopic
exploration, however, is not limited to a mere inspection of the lung and of the
pleural cavity, but can also implyothermore complex surgicalmaneuvers such
as (1) exploration of the fissure to verify the feasibility of intrafissural vascular
preparation,(2) opening the pericardium to verify the possibility of an intraper-
icardial ligature of the great vessels, or (3) thorough exploration of the medi-
astinum to dissect mediastinal lymph nodes. Exploration of the superior
mediastinum can involve sectioning of the azygos arch.
At the end of the exploration, the surgeon decides whether the tumor is re-
sectable and whether the resection can be accomplished by thoracoscopy or
thoracotomy. Patients in whom video exploration is not possible or patients
with doubtful findings are converted to thoracotomy exploration. The patients
whose conditions are judged operable at thoracoscopy are submitted to formal
resection under videothoracoscopy or thoracotomy immediately after thoraco-
scopy exploration.
RESULTS
Out of the present series of 1306 patients, VATS explora-
tion revealed causes of inoperability in 58 (4.4%) patients,
whereas in the remaining 1248 (95.6%) no sure causes of
unresectability were found. Among the 58 patients declared
inoperable, videothoracoscopy revealed a small-nodule pleu-
ral dissemination without pleural effusion in 32 (2.5%) and
a mediastinal infiltration in 22 (1.7%). In another 4 (0.3%)
patients in whom pneumonectomywould not have been toler-
ated, thoracoscopy detected the infiltration of the arterywithin
the fissure. In the remaining 1248 patients, thoracoscopy did
not reveal any cause of inoperability and the patientswere sub-
mitted to surgical resection. In 449 (34.4 %) patients with
stage I lung cancer, the resectionwas carried out thoracoscopi-
cally. Of these, 230 had a lobectomy with lymphadenectomy,The Journal of Thoracic and Ca6 had a video pneumonectomy, and 213 patients with poor
clinical and cardiorespiratory function had a video wedge
resection. The other 799 (61.2%) patients in whom VATS
exploration had not revealed or confirmed inoperability under-
went thoracotomy. Of these, 767 patients underwent lobec-
tomy (n ¼ 592), pneumonectomy (n ¼ 140), and tracheal
sleeve pneumonectomy (n¼ 35). In 32 (2.5%) patients, tho-
racotomy revealed inoperability. In 7 (0.5%) of them thoraco-
scopy had raised the suspicion of unresectability, but the
impossibility of carrying out the resection had not been con-
firmed. In these cases unresectability was due to infiltration
of the aorta (2 patients), intrapericardial invasion of the great
vessels (2 patients), intrafissural involvement of the artery in
2 patients who would not have tolerated pneumonectomy,
and, finally, intense peritumoral reaction in 1 young patient
who had undergone neoadjuvant chemotherapy. In 21
(1.6%), videothoracoscopic staging was impossible for tech-
nical reasons (diffuse adhesions sealing the pleural cavity in
17 and incomplete lung collapses owing to bronchial obstruc-
tion in 4). In another 4 cases (0.3%), which occurred at the be-
ginning of our experience, videoendoscopic assessment had
been inadequately conducted, and thoracotomy revealed ex-
tracapsularmediastinal lymphadenopathy (3 patients) or intra-
fissural invasion of the artery in 1 patient, not amenable to
pneumonectomy. Globally, video exploration was highly reli-
able in excluding conditions of unresectability with a negative
predictive value of 0.97. Morbidity and mortality specifically
referred to the preliminary video exploration has been absent.
With final pathologic staging used as the benchmark, the
percentage of patients whose cancer was understaged, cor-
rectly staged, and overstaged by preoperative CT was
30.4%, 48.7%, and 20.9%, respectively (Figure 2). The
global rate of understaging, correct staging, and overstaging
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FIGURE 1. Personal experience of routine videothoracoscopic explora-
tion carried out immediately before the planned resection from November
1991 to December 2007. CT, Computed tomography; VATS, video-assisted
thoracic surgery; TSPs, tracheal sleeve pneumonectomies; ETs, exploratory
thoracotomies.rdiovascular Surgery c Volume 138, Number 5 1207
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Pathologic staging 
IA IB IIA IIB IIIA IIIB IV
IA (278 pts) 147 82 22 3 18 4 2
IB (229 pts) 1 162 0 34 15 12 5
IIA (139 pts) 36 10 23 29 18 15 8
IIB (208 pts) 19 21 6 110 31 11 10
IIIA (159 pts) 23 19 5 32 71 7 2
IIIB (80 pts) 0 15 0 20 21 19 5
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FIGURE 2. A, CT staging compared with final pathologic staging. Dark gray cells indicate cases correctly staged by preoperative CT, light gray cells in-
dicate understaged cases, and white cells indicate overstaged cases. B, The percentage of correctly staged, understaged, and overstaged cases for each TNM
stage identified by CT, using the final pathologic staging as the benchmark. CT, Computed tomography.by thoracoscopywas 24.4%, 73.3%, and 0%, respectively. In
1.9% of cases VATS was not feasible. The global accuracy
rate was 73.3% (Figure 3). The difference in the percentage
of correctly stagedcases byCTandby thoracoscopycompared
by c2 test (139.11) was statistically significant (P< .0001).
Considering T descriptor, the rate of understaging, correct
staging, and overstaging by VATS was 3.8%, 96.2%, and
0%, respectively, compared with final pathologic staging.
The same T parameter preoperatively evaluated by CT had
been understaged, correctly staged, and overstaged in
12%, 85.6%, and 0.1%. The difference between CT and
thoracoscopy in evaluating T descriptor was highly signifi-
cant (c2 254.0; P< .0001).
Regarding N status, the rate of understaging, correct stag-
ing, and overstaging by VATS was 23%, 77%, and 0%,
respectively. At preoperative CT the rate had been 15.5%,
63.7%, and 20.8%, respectively. The difference was statis-
tically significant (c2 504; P< .0001).
Considering the 58 patients in whom thoracoscopy
revealed an unanticipated cause of inoperability and the1208 The Journal of Thoracic and Cardiovascular Su449 patients in whom thoracoscopy verified the feasibility
of a VATS resection, thoracoscopy spared an unnecessary
thoracotomy in 507 (38.8%) patients.
DISCUSSION
Accurate staging is essential to the appropriate manage-
ment of NSCLC, inasmuch as it predicts the prognosis and
guides strategic planning of treatment. Preoperative staging
is aimed at defining the nature, the size and local extension
of the tumor, lymph nodal status, and possible metastases.
Distant metastasis are usually adequately assessed in about
90% of patients by combining abdominal CT, brain CT or
MRI, and bone scan or whole body PET.1
CT of the chest plays a central role in locoregional stag-
ing, inasmuch as it provides key information about size of
the tumor and invasion of the fissures, the chest wall, or
the mediastinum.10 Unfortunately, in many cases CT cannot
precisely define the relationships between the tumor and the
surrounding structures. In particular, CT is not always able
to distinguish between simple contact and actual infiltration.rgery c November 2009
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IB (433 pts) 0 309 0 65 56 3 0
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FIGURE 3. A, TNM stages identified at thoracoscopic exploration compared with final pathologic staging.Dark gray cells indicate cases correctly staged by
thoracoscopy, light gray cells indicate understaged cases, and white cells indicate overstaged cases. B, The percentage of correctly staged, understaged, and
overstaged cases for each TNM stage identified by thoracoscopy, using the final pathologic staging as the benchmark.In our experience, T parameter was correctly staged by pre-
operative CT in 85.6% of cases. According to other recent
reports comparing CT findings with pathologic staging, T
description was accurate in only 24% to 71% of cases.11,12
Therefore ‘‘patients should not be denied the opportunity for
curative surgery on the basis of equivocal CT signs.’’13 Fur-
thermore, pleural carcinosis with very small nodules and
without pleural effusion usually goes undetected by CT.
Concerning mediastinal staging, a recent meta-analysis
reported pooled sensitivity of 57% and specificity of 82%
with a positive predictive value of 56% and a negative pre-
dictive value of 83%.1
Recent metabolic imaging techniques such as FDG-PET
or combined PET-CT have provided additional useful infor-
mation on tumor activity and extension. From a wide meta-
analysis, FDG-PET was more accurate than CT in evaluat-
ing mediastinal lymph node involvement.14 In particular,
a negative PET is considered highly reliable in excludingThe Journal of Thoracic and Camediastinal lymph node metastasis,1 and many authors sug-
gest that a negative mediastinal PET, with no lymph nodal
enlargement at CT, justifies the abstention from further in-
vasive surgical staging.10 Mediastinoscopy has long been
the gold standard and still remains a very important tool
for staging mediastinal lymph nodes. However, although
pretracheal nodes (stations 1 and 3), paratracheal nodes (sta-
tions 2 and 4), and anterior subcarinal nodes are accessible
through this technique, inferior mediastinal stations (sta-
tions 8 and 9) and aortopulmonary window and anterior me-
diastinal nodes (stations 5 and 6) cannot be reached and
sampled.15
Thoracoscopy provides optimal access to mediastinal sta-
tions 5, 6, 7, 8, and 9 and also to ipsilateral pretracheal and
paratracheal nodes, but contralateral lymphnodes can be
evaluated only by bilateral video exploration.8,16,17
Notwithstanding improvement in conventional diagnostic
tools, final staging still depends on surgical exploration andrdiovascular Surgery c Volume 138, Number 5 1209
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unexpected causes of inoperability and the procedure still
ends in a failed thoracotomy owing to the presence of met-
astatic pleural deposits or infiltration of the mediastinum
or vascular structures.1-7 We believe that VATS exploration
as the first step of the planned operation ensures thorough
exploration of the pleural cavity and permits adequate eval-
uation of hilar andmediastinal tissue and of ipsilateral lymph
node stations. The procedure is a valid substitute for thora-
cotomy exploration, but greatly reduces surgical trauma.
A number of authors have confirmed the efficacy of vid-
eothoracoscopic exploration for discovering small-nodule
pleural dissemination, for evaluating the infiltration of the
mediastinum, the artery within the fissure, or to reliably
assess mediastinal lymph nodes.8,18-20 In our experience,
video exploration proved useful in revealing causes of inop-
erability and highly reliable in excluding conditions of unre-
sectability, with a negative predictive value of 97%.
In the present study, thoracoscopy has resulted in a high
rate of correctly staged lesions (73.3%), significantly (P<
.0001) superior to CT (48.7%) (Figures 2 and 3). In describ-
ing T indicator, thoracoscopy proved very accurate (96.2%
of correctly staged cases), although it was less accurate
(77%) in evaluating N status. These findings are consistent
with the literature.11
The statusofmediastinal lymphnodes can change treatment
strategy, depending on the surgeon’s approach to N2 disease.
In our department, N2 lesions suggested by preoperative CT
are histologically confirmed and subjected to neoadjuvant
treatment. Unexpected N2 disease, discovered at operation,
undergoes surgical resection followed by adjuvant therapy.
Now that PET scanning is more readily available, we proceed
directly with surgical removal in patients with negative medi-
astinal PET results and planmediastinoscopy or thoracoscopy
inpatientswithPET-positivemediastinal adenopathy. In some
cases of suspected N2 or N3 disease, endobronchial ultraso-
nography and endoscopic ultrasonography are valid alterna-
tives to mediastinoscopy or thoracoscopy, even if they are
not yet extensively available in all centers.
We personally adopt videothoracoscopy as a routine proce-
dure before the intended surgical resection,8,9 as do several
other authors.11,21-24 In our experience, preliminary videothor-
acoscopy exploration of the pleural cavity revealed an unde-
tected cause of inoperability in 32 (2.5%) patients with
pleural metastatic dissemination without pleural effusion,
thus sparing a useless exploratory thoracotomy. Furthermore,
VATS exploration avoided a useless thoracotomy in another
22 (1.7%) patients in whom infiltration of mediastinal struc-
tures was found and in a further 4 (0.3%) patients ineligible
for pneumonectomy, in whom intrafissural invasion of the ar-
terywas ascertained. Overall video exploration spared explor-
atory thoracotomy in 58 (4.4%) patients. Other authors, in
a series of 650 patients with clinically staged resectable
NSCLC, observed 7% of inoperable disease at thoracoscopy,1210 The Journal of Thoracic and Cardiovascular Sumainly owing to pleural metastasis or direct invasion of vital
structures.25 The rate of exploratory thoracotomies after con-
ventional staging in the literature ranges from 3% to 25%.2-7
In a previous analysis of our experience of more than 2000
pulmonary resections carried out between 1967 and 1980,
the rate of exploratory thoracotomy had been 19% but had de-
creased to 11.6% in the 1980s (1980–1991), after the progres-
sive introduction of CT scanning in preoperative evaluation.8
This observation was consistent with other experiences.3 In
our latest series of patients, after the introduction of VATS ex-
ploration, the rate of exploratory thoracotomy was 2.5%. The
only relevant variation in patient selection protocol had been
the adoption of systematic video exploration once a patient
had been judged to have operable disease on the basis of con-
ventional clinical staging. However, some other factors could
have influenced the reduction of the exploratory thoracoto-
mies. In fact, if we add to the 58 (4.4%) cases in which thor-
acoscopy revealed an unanticipated cause of inoperability the
32 (2.5%) cases in which an exploratory thoracotomy was
done despite preliminary thoracoscopy, the exploratory thora-
cotomy rate would have been 6.9%. The difference (4.7%)
between our previous 11.6% rate of exploratory thoracotomy
and post-VATS rate could therefore be due to other factors.
A progressive decrease of failed thoracotomies is com-
monly retrieved in the literature.26,27 Inasmuch as we have
not mademajor changes in the patient selection protocol other
than the introduction of preliminary thoracoscopy, we can
only infer the factors contributing to the improvement of the
failed thoracotomy rate. We must point out that in the same
years CT scanners have evolved, helical CT have become
more extensively available, and radiologists have been sup-
ported by more sophisticated computerized processing of
images. Furthermore, as it has been commonly observed
over these years,26 we have recorded a progressive inversion
from a prevalence of central squamous cell tumors to adeno-
carcinomas. In the present series, we observed 29.5% of squa-
mous cell tumors and 49.7% of adenocarcinoma (including
9.4% of bronchoalveolar carcinomas). This could also have
influenced the decreasing of failed thoracotomy rate.
Without VATS, the 58 patients found at videothoraco-
scopy to have unresectable disease would have undergone
an exploratory thoracotomy. Furthermore, it should be
pointed out that 449 (34.4%) patients had a fully thoraco-
scopic resection after preliminary thoracoscopy had con-
firmed the feasibility of a minimally invasive operation.
Thus, thoracoscopy spared 507 (38.8%) unnecessary thora-
cotomies. However, 25 patients, for whom VATS had not
been adequately carried out owing to diffuse pleural adhe-
sions, incomplete lung collapse, and poorly developed fis-
sure, finally underwent exploratory thoracotomy, despite
preliminary thoracoscopy.
Our experience, therefore, suggests that thoracoscopy
limits the rate of exploratory thoracotomies, but technical
or anatomic conditions can impair adequate exploration.rgery c November 2009
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resectability, the procedure was concluded, whereas it was
converted to thoracotomy in any case of doubt. VATS is an in-
valuable tool in sparing unnecessary thoracotomies when it
finds unequivocal signs of unresectable tumor, but sometimes
open exploration is necessary to assess resectability, especially
when an extensive dissection from delicate vital structures is
required. This is a limitation of VATS exploration, although
our experience suggests that in these cases, assessing inoper-
abilitywas verydifficult even after conversion to thoracotomy.
Validity of the thoracoscopic mediastinal staging has
already been proved,8,16,17 but the impact on surgical strat-
egy is more debatable inasmuch as it is related to the attitude
of the surgical team toward N2 disease. Indeed, the approach
to N2 disease has been changing over the past 15 years. Even
if most surgeons prefer submitting patients with N2 disease
to neoadjuvant therapy, some respected experts still main-
tain a different approach. The extensive adoption of PET
scanning will probably change strategies over the next years.
In experienced hands, preliminary video exploration adds
only a short time to procedures. Pleural dissemination is
readily detected, whereas the evaluation of mediastinal
structures can require a longer time, especially when the
tumor is in close contact with vital structures. In other
instances, the maneuvers for evaluating resectability or actu-
ally dissecting the tumor to perform a videoendoscopic
resection are not clearly separated. We have not conducted
a systematic comparison of the costs, but they are consider-
ably limited by adopting reusable instruments, as only a cou-
ple of ports, scissors, and forceps are necessary to carry out
the exploration. The video equipment is usually already
present in the theater for many other thoracoscopic or lapa-
roscopic procedure.
In our experience, preliminary thoracoscopy did not in-
crease the morbidity and avoided a significant number of
useless thoracotomies. This is even more important in pa-
tients with relatively poor cardiopulmonary function.
Limitations to the Study
Although the results are encouraging, we must also point
out some limitations of our study. The main limitation is that
this is simply a retrospective review of a series accumulated
over a relatively long period in a single institution. The ret-
rospective nature of the study may imply a potential bias in
patient selection and a greater difficulty in precise reporting
of clinical aspects such as descriptions of intraoperative find-
ings and minor complications. The fact that the experience
derives from a single institution adds homogeneity to the
procedures performed but limits the general applicability
or reproducibility of the findings. The relatively long period
can entail progressive modifications of the imaging tech-
niques and of the patient population, difficult to identify
and measure. Finally, the evaluation of costs and time of
the procedure, as well as postoperative hospital stay, largelyThe Journal of Thoracic and Cadepend on local situations that can change greatly. Even if
nonstatististical comparison has been conducted between
the present and our previous ‘‘historical’’ series, the crude
datum of spared thoracotomies (undetectable pleural minute
pleural disseminations without effusion and resections car-
ried out thoracoscopically) is self-evident.
In our opinion, 40% of spared thoracotomies is a very ap-
preciable result, especially taking into account that prelimi-
nary exploration did not add morbidity or mortality and is,
in most instances, a rapid procedure at reasonable costs. The
magnitude of this impact, however, largely depends on the ag-
gressiveness of the surgeon in performing a thoracoscopic re-
section. We must recall that despite our strong belief in the
thoracoscopic approach, since the beginningofour experience
we adopted very strict criteria for choosing to carry out amajor
resection for cancer by thoracoscopy,waiting for confirmation
of the long-term oncologic validity of the procedure.28 In fact,
we deliberately converted to open resection several lobecto-
mies that could have been technically possible by thoraco-
scopy. The proportion of patients indicating a VATS
sublobar resection owing to poor conditions will also affect
the impact of the strategy. VATS lobectomies are no longer
experimental procedures and are increasingly performed
even among general thoracic surgeons who do not work in
specifically dedicated institutions. According to a recent re-
port based on the Society of Thoracic Surgeons database, up
to 20% of lobectomies have been performed as a VATS oper-
ation, and the article does not include the rate of sublobar
resections carried out thoracoscopically.29 All these consider-
ations lead to the possibility of an ever-increasing impact of
minimally invasive techniques in NSCLC management.
CONCLUSIONS
In our opinion, even considering that videothoracoscopy
has not changed the management in more than 50% of pa-
tients, the clinical benefit of sparing an unnecessary thoracot-
omy in 40% of patients is worthwhile (especially in frail
patients), performing a preliminary thoracoscopy to rule out
causes of inoperability or to decide whether resection can be
carried out through videothoracoscopic or conventional pro-
cedures. On these bases and with these caveats, we would
recommend an extensive adoption of videothoracoscopic
exploration as the initial step of the planned operation.
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